Blockade of insulin-like growth factor I receptor function inhibits growth and angiogenesis of colon cancer

Clinical Cancer Research

Volumn 8, Issue 10, 2002, Pages 3259-3269

  Reinmuth, Niels ^a   Liu, Wenbiao ^a   Fan, Fan ^a   Jung, Young D ^a   Ahmad, Syed A ^a   Stoeltzing, Oliver ^a   Bucana, Corazon D ^a   Radinsky, Robert ^a   Ellis, Lee M ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MESSENGER RNA; RECOMBINANT SOMATOMEDIN C; SOMATOMEDIN C RECEPTOR; VASCULOTROPIN;

ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER INHIBITION; CARCINOGENICITY; CELL STRAIN HT29; COLON CANCER; CONTROLLED STUDY; DRUG RECEPTOR BINDING; EXPRESSION VECTOR; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; MALE; MONOLAYER CULTURE; MOUSE; NONHUMAN; NUDE MOUSE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RECEPTOR BLOCKING; TUMOR VASCULARIZATION;

ANIMALS; ANTIGENS, CD31; APOPTOSIS; CELL DIVISION; COLONIC NEOPLASMS; ENDOTHELIAL GROWTH FACTORS; GENES, DOMINANT; HUMANS; IMMUNOENZYME TECHNIQUES; IN SITU NICK-END LABELING; INJECTIONS, SUBCUTANEOUS; INSULIN-LIKE GROWTH FACTOR I; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; LIVER NEOPLASMS; LYMPHOKINES; MALE; MICE; MICE, NUDE; MITOGEN-ACTIVATED PROTEIN KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASE 3; MITOGEN-ACTIVATED PROTEIN KINASES; NEOVASCULARIZATION, PATHOLOGIC; PHOSPHORYLATION; PROLIFERATING CELL NUCLEAR ANTIGEN; RECEPTOR, IGF TYPE 1; RNA, MESSENGER; TRANSFECTION; TUMOR CELLS, CULTURED; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTORS;

EID: 0036793827     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (48)

1. Hakam, A., Yeatman, T. J., Lu, L., Mora, L., Marcet, G., Nicosia, S. V., Karl, R. C., and Coppola, D. Expression of insulin-like growth factor-1 receptor in human colorectal cancer. Hum. Pathol., 30: 1128-1133, 1999.
2. Freier, S., Weiss, O., Eran, M., Flyvbjerg, A., Dahan, R., Nephesh, I., Safra, T., Shiloni, E., and Raz, I. Expression of the insulin-like growth factors and their receptors in adenocarcinoma of the colon. Gut, 44: 704-708, 1999.
3. Michell, N. P., Langman, M. J., and Eggo, M. C. Insulin-like growth factors and their binding proteins in human colonocytes: preferential degradation of insulin-like growth factor binding protein 2 in colonic cancers. Br. J. Cancer, 76: 60-66, 1997.
4. Baserga, R., Hongo, A., Rubini, M., Prisco, M., and Valentinis, B. The IGF-I receptor in cell growth, transformation and apoptosis. Biochim. Biophys. Acta, 1332: F105-F126, 1997.
5. Wang, L. M., Myers, M. G., Jr., Sun, X. J., Aaronson, S. A., White, M., and Pierce, J. H. IRS-1: essential for insulin- and IL-4-stimulated mitogenesis in hematopoietic cells. Science (Wash. DC), 261: 1591-1594, 1993.
6. Flossmann-Kast, B. B., Jehle, P. M., Hoeflich, A., Adler, G., and Lutz, M. P. Src stimulates insulin-like growth factor I (IGF-I)-dependent cell proliferation by increasing IGF-I receptor number in human pancreatic carcinoma cells. Cancer Res., 58: 3551-3554, 1998.
7. Chen, Y., Capron, L., Magnusson, J. O., Wallby, L. A., and Arnqvist, H. J. Insulin-like growth factor-1 stimulates vascular smooth muscle cell proliferation in rat aorta in vivo. Growth Horm. IGF Res., 8: 299-303, 1998.
8. Singh, P., Dai, B., Yallampalli, C., and Xu, Z. Expression of IGF-II and IGF-binding proteins by colon cancer cells in relation to growth response to IGFs. Am. J. Physiol., 267: G608-G617, 1994.
9. Akagi, Y., Liu, W., Zebrowski, B., Xie, K., and Ellis, L. M. Regulation of vascular endothelial growth factor expression in human colon cancer by insulin-like growth factor-I. Cancer Res., 58: 4008-4014, 1998.
10. Warren, R. S., Yuan, H., Matli, M. R., Ferrara, N., and Donner, D. B. Induction of vascular endothelial growth factor by insulin-like growth factor I in colorectal carcinoma. J. Biol. Chem., 271: 29483-29488, 1996.
11. Brown, L. F., Detmar, M., Claffey, K., Nagy, J. A., Feng, D., Dvorak, A. M., and Dvorak, H. F. Vascular permeability factor/vascular endothelial growth factor: a multifunctional angiogenic cytokine. In: I. Goldberg and E. Rosen (eds.), Regulation of Angiogenesis. Basel, Switzerland: Birkhauser/Verlag, 1997.
12. Folkman, J. The role of angiogenesis in tumor growth. Semin. Cancer Biol., 3: 65-71, 1992.
13. Ellis, L. M., and Fidler, I. J. Angiogenesis and metastasis. Eur. J. Cancer, 32A: 2451-2460, 1996.
14. Ellis, L. M., Takahashi, Y., Liu, W., and Shaheen, R. M. Vascular endothelial growth factor in human colon cancer: biology and therapeutic implications. Oncologist, 5: 11-15, 2000.
15. Singh, P., and Rubin, N. Insulin-like growth factors and binding proteins in colon cancer. Gastroenterology, 105: 1218-1237, 1993.
16. Singh, P., Dai, B., Dhruva, B., and Widen, S. G. Episomal expression of sense and antisense insulin-like growth factor (IGF)-binding protein-4 complementary DNA alters the mitogenic response of a human colon cancer cell line (HT-29) by mechanisms that are independent of and dependent upon IGF-I. Cancer Res., 54: 6563-6570, 1994.
17. Werner, H., and Le Roith, D. The insulin-like growth factor-I receptor signaling pathways are important for tumorigenesis and inhibition of apoptosis. Crit. Rev. Oncog., 8: 71-92, 1997.
18. Liu, J. P., Baker, J., Perkins, A. S., Robertson, E. J., and Efstratiadis, A. Mice carrying null mutations of the genes encoding insulin-like growth factor I (Igf-1) and type 1 IGF receptor (Igf1r). Cell, 75: 59-72, 1993.
19. Prager, D., Yamasaki, H., Weber, M. M., Gebremedhin, S., and Melmed, S. Human insulin-like growth factor I receptor function in pituitary cells is suppressed by a dominant negative mutant. J. Clin. Investig., 90: 2117-2122, 1992.
20. Prager, D., Li, H. L., Asa, S., and Melmed, S. Dominant negative inhibition of tumorigenesis in vivo by human insulin-like growth factor I receptor mutant. Proc. Natl. Acad. Sci. USA, 91: 2181-2185, 1994.
21. Koura, A. N., Liu, W., Kitadai, Y., Singh, R. K., Radinsky, R., and Ellis, L. M. Regulation of vascular endothelial growth factor expression in human colon carcinoma cells by cell density. Cancer Res., 56: 3891-3894, 1996.
22. Ellis, L. M., Liu, W., and Wilson, M. Down-regulation of vascular endothelial growth factor in human colon carcinoma cell lines by antisense transfection decreases endothelial cell proliferation. Surgery (St Louis), 120: 871-878, 1996.
23. Berse, B., Brown, L. F., Van de Water, L., Dvorak, H. F., and Senger, D. R. Vascular permeability factor (vascular endothelial growth factor) gene is expressed differentially in normal tissues, macrophages, and tumors. Mol. Biol. Cell, 3: 211-220, 1992.
24. Reinmuth, N., Liu, W., Jung, Y. D., Ahmad, S. A., Shaheen, R. M., Fan, F., Bucana, C. D., McMahon, G., Gallick, G. E., and Ellis, L. M. Induction of VEGF in perivascular cells defines a potential paracrine mechanism for endothelial cell survival. FASEB J., 15: 1239-1241, 2001.
25. 189. Proc. Natl. Acad. Sci. USA, 94: 12081-12087, 1997.
26. Miele, C., Rochford, J. J., Filippa, N., Giorgetti-Peraldi, S., and Van Obberghen, E. Insulin and insulin-like growth factor-I induce vascular endothelial growth factor mRNA expression via different signaling pathways. J. Biol. Chem., 275: 21695-21702, 2000.
27. Takahashi, Y., Bucana, C. D., Cleary, K. R., and Ellis, L. M. p53, vessel count, and vascular endothelial growth factor expression in human colon cancer. Int. J. Cancer, 79: 34-38, 1998.
28. Bruns, C. J., Solorzano, C. C., Harbison, M. T., Ozawa, S., Tsan, R., Fan, D., Abbruzzese, J., Traxler, P., Buchdunger, E., Radinsky, R., and Fidler, I. J. Blockade of the epidermal growth factor receptor signaling by a novel tyrosine kinase inhibitor leads to apoptosis of endothelial cells and therapy of human pancreatic carcinoma. Cancer Res., 60: 2926-2935, 2000.
29. Shaheen, R. M., Davis, D. W., Liu, W., Zebrowski, B. K., Wilson, M. R., Bucana, C. D., McConkey, D. J., McMahon, G., and Ellis, L. M. Antiangiogenic therapy targeting the tyrosine kinase receptor for vascular endothelial growth factor receptor inhibits the growth of colon cancer liver metastasis and induces tumor and endothelial cell apoptosis. Cancer Res., 59: 5412-5416, 1999.
30. Solorzano, C. C., Jung, Y. D., Bucana, C. D., McConkey, D. J., Gallick, G. E., McMahon, G., and Ellis, L. M. In vivo intracellular signaling as a marker of antiangiogenic activity. Cancer Res., 61: 7048-7051, 2001.
31. Takahashi, Y., Kitadai, Y., Bucana, C. D., Cleary, K. R., and Ellis, L. M. Expression of vascular endothelial growth factor and its receptor, KDR, correlates with vascularity, metastasis, and proliferation of human colon cancer. Cancer Res., 55: 3964-3968, 1995.
32. Weidner, N. Intratumor microvessel density as a prognostic factor in cancer. Am. J. Pathol., 147: 9-19, 1995.
33. Baserga, R., Resnicoff, M., and Dews, M. The IGF-I receptor and cancer. Endocrine, 7: 99-102, 1997.
34. Rubin, R., and Baserga, R. Insulin-like growth factor-I receptor. Its role in cell proliferation, apoptosis, and tumorigenicity. Lab. Investig., 73: 311-331, 1995.
35. Nakamura, K., Hongo, A., Kodama, J., Miyagi, Y., Yoshinouchi, M., and Kudo, T. Down-regulation of the insulin-like growth factor I receptor by antisense RNA can reverse the transformed phenotype of human cervical cancer cell lines. Cancer Res., 60: 760-765, 2000.
36. Shapiro, D. N., Jones, B. G., Shapiro, L. H., Dias, P., and Houghton, P. J. Antisense-mediated reduction in insulin-like growth factor-I receptor expression suppresses the malignant phenotype of a human alveolar rhabdomyosarcoma. J. Clin. Investig., 94: 1235-1242, 1994.
37. D'Ambrosio, C., Ferber, A., Resnicoff, M., and Baserga, R. A soluble insulin-like growth factor I receptor that induces apoptosis of tumor cells in vivo and inhibits tumorigenesis. Cancer Res., 56: 4013-4020, 1996.
38. Butler, A. A., Blakesley, V. A., Poulaki, V., Tsokos, M., Wood, T. L., LeRoith, D., and Pouliki, V. Stimulation of tumor growth by recombinant human insulin-like growth factor-I (IGF-I) is dependent on the dose and the level of IGF-I receptor expression [published erratum appears in Cancer Res., 58: 5630, 1998]. Cancer Res., 58: 3021-3027, 1998.
39. Baserga, R., Resnicoff, M., D'Ambrosio, C., and Valentinis, B. The role of the IGF-I receptor in apoptosis. Vitam. Horm., 53: 65-98, 1997.
40. Railo, M. J., von Smitten, K., and Pekonen, F. The prognostic value of insulin-like growth factor-I in breast cancer patients. Results of a follow-up study on 126 patients. Eur. J. Cancer, 3: 307-311, 1994.
41. van Dam, P. A., Vergote, I. B., Lowe, D. G., Watson, J. V., van Damme, P., van der Auwera, J. C., and Shepherd, J. H. Expression of c-erbB-2, c-myc, and c-ras oncoproteins, insulin-like growth factor receptor I, and epidermal growth factor receptor in ovarian carcinoma. J. Clin. Pathol., 47: 914-919, 1994.
42. Tokunaga, T., Oshika, Y., Abe, Y., Ozeki, Y., Sadahiro, S., Kijima, H., Tsuchida, T., Yamazaki, H., Ueyama, Y., Tamaoki, N., and Nakamura, M. Vascular endothelial growth factor (VEGF) mRNA isoform expression pattern is correlated with liver metastasis and poor prognosis in colon cancer. Br. J. Cancer, 77: 998-1002, 1998.
43. Yuan, A., Yu, C. J., Kuo, S. H., Chen, W. J., Lin, F. Y., Luh, K. T., Yang, P. C., and Lee, Y. C. Vascular endothelial growth factor 189 mRNA isoform expression specifically correlates with tumor angiogenesis, patient survival, and postoperative relapse in non-small-cell lung cancer. J. Clin. Oncol., 19: 432-441, 2001.
44. Kim, B., Cheng, H. L., Margolis, B., and Feldman, E. L. Insulin receptor substrate 2 and Shc play different roles in insulin-like growth factor I signaling. J. Biol. Chem., 273: 34543-34550, 1998.
45. Reiss, K., D'Ambrosio, C., Tu, X., Tu, C., and Baserga, R. Inhibition of tumor growth by a dominant negative mutant of the insulin-like growth factor I receptor with a bystander effect. Clin. Cancer Res., 4: 2647-2655, 1998.
46. Szepeshazi, K., Schally, A. V., Groot, K., Armatis, P., Halmos, G., Herbert, F., Szende, B., Varga, J. L., and Zarandi, M. Antagonists of growth hormone-releasing hormone (GH-RH) inhibit IGF-II production and growth of HT-29 human colon cancers. Br. J. Cancer, 82: 1724-1731, 2000.
47. O'Connor, R., Kauffmann-Zeh, A., Liu, Y., Lehar, S., Evan, G. I., Baserga, R., and Blattler, W. A. Identification of domains of the insulin-like growth factor I receptor that are required for protection from apoptosis. Mol. Cell. Biol., 17: 427-435, 1997.
48. Romano, G., Prisco, M., Zanocco-Marani, T., Peruzzi, F., Valentinis, B., and Baserga, R. Dissociation between resistance to apoptosis and the transformed phenotype in IGF-I receptor signaling. J. Cell. Biochem., 72: 294-310, 1999.